Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative URGN - UroGen Pharma Ltd.
93.3 M
LAST VALUE
3.23%
2 YEAR CAGR
18.71%
5 YEAR CAGR
56.55%
10 YEAR CAGR